The expression of Importin 13 in lung cancer

Nuclear distribution of RFPL3 mediated by importin 13 and the hTERT regulation mechanism

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027076

Enrollment

Unknown

Registered

2019-10-30

Start date

2019-10-30

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Case Series:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: non-small cell lung cancer confirmed with pathology

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Importin 13;	—

Countries

China

Contacts

Public ContactXin Cai

Medical Oncology Department, the First Affiliated Hospital of Dalian Medical University

babydocone@126.com+86 18098876693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026